How long does it take for Laos Element Pharmaceuticals to be resistant to lorlatinib?

Lorlatinib/Lorlatinib is an anti-tumor agent used to treat patients with ALK-positive or ROS-1-positive non-small cell lung cancer (NSCLC). The therapeutic effect is significant. How long does it take for Laos Element Pharmaceuticals to be resistant to lorlatinib?

The resistance time to lorlatinib varies from person to person, The average resistance time is about14 months, but the average resistance time in intracranial (lung cancer metastasis) is longer. Before starting lorlatinib, it is necessary to determine the patient's condition: confirm the presence of ALK in tumor specimens of patients with metastatic non-small cell lung cancer; verify the pregnancy status of women of reproductive potential before starting treatment. Assess serum cholesterol and triglyceride concentrations before initiating treatment and initiate or optimize lipid-lowering therapy as clinically indicated; perform an electrocardiogram before initiating treatment; assess blood pressure before initiating treatment, which must be controlled before initiating medication; assess fasting blood glucose concentrations before initiating medication; evaluate concomitant treatments, including prescription drugs, over-the-counter drugs, and dietary or herbal supplements. Monitor blood pressure after 2 weeks of treatment and at least once a month during treatment. Monitor serum cholesterol and triglyceride concentrations 1 months and 2 months after starting treatment, and then periodically thereafter to initiate or optimize lipid-lowering therapy as clinically indicated. Monitor electrocardiogram regularly during treatment. Monitor fasting blood glucose concentrations regularly during treatment. The current retail price of generic drugs from 100mg30pills3 is about one thousand. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about overseas high-quality drugs for you.